Home/FoRx Therapeutics/Jens Würthner
JW

Jens Würthner

Chief Medical Officer

FoRx Therapeutics

Therapeutic Areas

FoRx Therapeutics Pipeline

DrugIndicationPhase
FORX-428Advanced Solid Tumors (treatment-resistant cancers)Phase 1